346499 <common-name>(5z)-5-[[3-(3-chloro-4-methoxyphenyl)-1-phenylpyrazol-4-yl]methylidene]-3-heptyl-2-sulfanylidene-1,3-thiazolidin-4-one</common-name> <description>(5z)-5-[[3-(3-chloro-4-methoxyphenyl)-1-phenylpyrazol-4-yl]methylidene]-3-heptyl-2-sulfanylidene-1,3-thiazolidin-4-one is a chemical compound with the formula C27H28ClN3O2S2. With an average molecular weight of 526.10 g/mol, (5z)-5-[[3-(3-chloro-4-methoxyphenyl)-1-phenylpyrazol-4-yl]methylidene]-3-heptyl-2-sulfanylidene-1,3-thiazolidin-4-one is a heavy molecule.</description> <cas>624724-39-6</cas> <pubchem-id>16429249</pubchem-id> <chemical-formula>C27H28ClN3O2S2</chemical-formula> <weight>526.1</weight> <appearance nil="true"/> <melting-point nil="true"/> <boiling-point nil="true"/> <density nil="true"/> <solubility nil="true"/> <specific-gravity nil="true"/> <flash-point nil="true"/> <vapour-pressure nil="true"/> <route-of-exposure nil="true"/> <target nil="true"/> <mechanism-of-toxicity nil="true"/> <metabolism nil="true"/> <toxicity nil="true"/> <lethaldose nil="true"/> <carcinogenicity nil="true"/> <use-source nil="true"/> <min-risk-level nil="true"/> <health-effects nil="true"/> <symptoms nil="true"/> <treatment nil="true"/> <created-at type="dateTime">2026-08-31T09:58:21Z</created-at> <updated-at type="dateTime">2026-08-31T09:58:21Z</updated-at> <interacting-proteins nil="true"/> <wikipedia nil="true"/> <uniprot-id nil="true"/> <kegg-compound-id nil="true"/> <omim-id nil="true"/> <chebi-id nil="true"/> <biocyc-id nil="true"/> <ctd-id nil="true"/> <stitch-id nil="true"/> <drugbank-id nil="true"/> <pdb-id nil="true"/> <actor-id nil="true"/> <organism nil="true"/> <export type="boolean">true</export> <metabolizing-proteins nil="true"/> <transporting-proteins nil="true"/> <moldb-smiles>CCCCCCCN1C(=O)C(=CC2=CN(N=C2C3=CC(=C(C=C3)OC)Cl)C4=CC=CC=C4)SC1=S</moldb-smiles> <moldb-formula>C27H28ClN3O2S2</moldb-formula> <moldb-inchi>InChI=1S/C27H28ClN3O2S2/c1-3-4-5-6-10-15-30-26(32)24(35-27(30)34)17-20-18-31(21-11-8-7-9-12-21)29-25(20)19-13-14-23(33-2)22(28)16-19/h7-9,11-14,16-18H,3-6,10,15H2,1-2H3/b24-17-</moldb-inchi> <moldb-inchikey>NHEPJNKSHFRKNB-ULJHMMPZSA-N</moldb-inchikey> <moldb-average-mass type="decimal" nil="true"/> <moldb-mono-mass type="decimal">525.1311472</moldb-mono-mass> <origin nil="true"/> <state nil="true"/> <logp>8.1</logp> <hmdb-id nil="true"/> <chembl-id nil="true"/> <chemspider-id nil="true"/> <structure-image-file-name nil="true"/> <structure-image-content-type nil="true"/> <structure-image-file-size type="integer" nil="true"/> <structure-image-updated-at type="dateTime" nil="true"/> <biodb-id nil="true"/> <synthesis-reference nil="true"/> <structure-image-caption nil="true"/> <chemdb-id>CHEM342392</chemdb-id> <dsstox-id nil="true"/> <toxcast-id nil="true"/> <stoff-ident-origin nil="true"/> <stoff-ident-id nil="true"/> <susdat-id nil="true"/> <iupac>(5z)-5-[[3-(3-chloro-4-methoxyphenyl)-1-phenylpyrazol-4-yl]methylidene]-3-heptyl-2-sulfanylidene-1,3-thiazolidin-4-one</iupac> <moldb-polar-surface-area nil="true"/> <moldb-refractivity nil="true"/> <moldb-polarizability nil="true"/> <moldb-rotatable-bond-count nil="true"/> <moldb-acceptor-count nil="true"/> <moldb-donor-count nil="true"/> <moldb-pka-strongest-acidic nil="true"/> <moldb-pka-strongest-basic nil="true"/> <moldb-physiological-charge nil="true"/> <moldb-number-of-rings nil="true"/> <moldb-alogps-logp nil="true"/> <moldb-alogps-logs nil="true"/> <moldb-alogps-solubility nil="true"/> <kingdom>Organic compounds</kingdom> <superklass>Organoheterocyclic compounds</superklass> <klass>Azoles</klass> <subklass>Pyrazoles</subklass> <paper-count type="integer" nil="true"/> <sync-id>CED0296852</sync-id> <structure-inchikey>NHEPJNKSHFRKNB-UHFFFAOYSA-N</structure-inchikey> <structure-fingerprint>800240000000000000000000000000000100000000400000404002000020100000000002002004000000000000000000800000000000000000000000c000000900000000000000200000100003000000000000000000000000200000000000400001001100048000080001001080400000000000000000000041c0000000800002000000014000800000000100000000000000000000000000000000000000000000080000000000000028010002020200040000000080000000000000000000000000000000000010000000040000000200000000000000000040000004000040000000810000000000080030000000000200000008</structure-fingerprint> <structure-pattern-fingerprint>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</structure-pattern-fingerprint> <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAjAAAAJgAAAIABBgBgAAAAAQMGAGAAAAAC AgYAYAAAAAICBgBgAAAAAgIGAGAAAAACAgYAYAAAAAICBgBgAAAAAgIHACgA AAADAwYAKAAAAAMECAAoAAAAAwIGACgAAAADBAYAaAAAAAMDAQZAKAAAAAME BkBoAAAAAwMBB0AoAAAAAwMHQCgAAAADAwZAKAAAAAMEBkAoAAAAAwQGQGgA AAADAwEGQCgAAAADBAZAKAAAAAMEBkBoAAAAAwMBBkBoAAAAAwMBCAAoAAAA AwIGAGAAAAABAxEAIAAAAAEGQCgAAAADBAZAaAAAAAMDAQZAaAAAAAMDAQZA aAAAAAMDAQZAaAAAAAMDAQZAaAAAAAMDARAAIAAAAAIGACgAAAADBBAAKAAA AAMCCwABAAECAAIDAAMEAAQFAAUGAAYHAAcIIAgJKAIICiAKCygCCwwgDA1o DA0OaAwOD2gMDxBoDBARIBESaAwSE2gMExRoDBQVaAwVFmgMFBcgFxgAExkA DhogGhtoDBscaAwcHWgMHR5oDB4faAwKIAAgIQAhIigCIQcgEAxoDBYRaAwf GmgMQgQAAAAFBwgKICEFDQwQDw4GEhMUFRYRBhscHR4fGhcEAAAAAAAAABY= </structure-pickle> <structure-indexed-at type="dateTime">2026-09-19T05:45:13Z</structure-indexed-at> </compound>